SCHEMBL30855145

SCHEMBL30855145

CC(C)(C)OC(=O)N1CCOC=C1c1cc(Cl)cc(-c2coc(N)n2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.35
USP30 Q70CQ3 2/20 0.34
UCHL1 P09936 1/20 0.34
LTA4H P09960 1/20 0.33
PIK3CA P42336 2/20 0.33
ABCB1 P08183 2/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
ADORA2A P29274 2/20 0.32
CSNK2A1 P68400 2/20 0.31
CSNK2A2 P19784 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
ADORA1 P30542 1/20 0.31
NR1H2 P55055 1/20 0.30
SMARCA2 P51531 1/20 0.30
SMARCA4 P51532 1/20 0.30
PBRM1 Q86U86 1/20 0.30
ADK P55263 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29334170 1.00 GPR119 (0.35) GPR119USP30UCHL1LTA4HPIK3CA
SCHEMBL31224635 0.79 HSP90AA1 (0.36) USP30UCHL1PIK3CAABCB1ABCG2
SCHEMBL29334347 0.76 GPR119 (0.38) GPR119USP30MEN1KMT2ANR1H2
SCHEMBL30855045 0.76 GPR119 (0.38) GPR119USP30MEN1KMT2ANR1H2
SCHEMBL29334081 0.74 STS (0.33) USP30UCHL1MEN1KMT2A
SCHEMBL29334072 0.73 USP30 (0.38) USP30MEN1KMT2A
SCHEMBL14839570 0.73 GPR119 (0.42) GPR119USP30NR1H2
SCHEMBL14839844 0.70 CKS1B (0.43) GPR119USP30ABCB1ABCG2
SCHEMBL29334085 0.70 USP30 (0.33) GPR119USP30UCHL1MEN1KMT2A
SCHEMBL14839556 0.69 ESR2 (0.42) GPR119USP30MEN1KMT2ANR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594308-A1 N-ACRYLOYLMORPHOLINE DERIVATIVES AS KEAP1 MODULATORS AND USES THEREOF Vividion Therapeutics, Inc. (US) 2025-08-06 EP disclosed
WO-2024073587-A1 N-ACRYLOYLMORPHOLINE DERIVATIVES AS KEAP1 MODULATORS AND USES THEREOF VIVIDION THERAPEUTICS, INC. (US) 2024-04-04 WO disclosed